Abstract
Specific immunotherapy (SIT) is the only treatment with proved long-term curative potential in patients with allergic disease. Allergen-specific IgE is the causative agent of allergic disease, and antibodies contribute to SIT, but the effects of SIT on aeroallergen-specific B-cell repertoires are not well understood.
Original language | English |
---|---|
Pages (from-to) | 1535-1544 |
Journal | The Journal of Allergy and Clinical Immunology |
Volume | 137 |
Issue number | 5 |
Early online date | 2015 Nov 7 |
DOIs | |
Publication status | Published - 2016 |
Subject classification (UKÄ)
- Respiratory Medicine and Allergy